These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 16828804

  • 1. Rasagiline-associated motor improvement in PD occurs without worsening of cognitive and behavioral symptoms.
    Elmer L, Schwid S, Eberly S, Goetz C, Fahn S, Kieburtz K, Oakes D, Blindauer K, Salzman P, Oren S, Prisco UL, Stern M, Shoulson I, Parkinson Study Group TEMPO, PRESTO Investigators.
    J Neurol Sci; 2006 Oct 25; 248(1-2):78-83. PubMed ID: 16828804
    [Abstract] [Full Text] [Related]

  • 2. A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study.
    Parkinson Study Group.
    Arch Neurol; 2005 Feb 25; 62(2):241-8. PubMed ID: 15710852
    [Abstract] [Full Text] [Related]

  • 3. Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients.
    Stern MB, Marek KL, Friedman J, Hauser RA, LeWitt PA, Tarsy D, Olanow CW.
    Mov Disord; 2004 Aug 25; 19(8):916-23. PubMed ID: 15300656
    [Abstract] [Full Text] [Related]

  • 4. Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.
    Chen JJ, Swope DM, Dashtipour K.
    Clin Ther; 2007 Sep 25; 29(9):1825-49. PubMed ID: 18035186
    [Abstract] [Full Text] [Related]

  • 5. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH, Klasser M, Reichmann H.
    Fortschr Neurol Psychiatr; 2008 Oct 25; 76(10):594-9. PubMed ID: 18833504
    [Abstract] [Full Text] [Related]

  • 6. Monamine oxidase inhibitors: current and emerging agents for Parkinson disease.
    Fernandez HH, Chen JJ.
    Clin Neuropharmacol; 2007 Oct 25; 30(3):150-68. PubMed ID: 17545750
    [Abstract] [Full Text] [Related]

  • 7. Rasagiline improves quality of life in patients with early Parkinson's disease.
    Biglan KM, Schwid S, Eberly S, Blindauer K, Fahn S, Goren T, Kieburtz K, Oakes D, Plumb S, Siderowf A, Stern M, Shoulson I, Parkinson Study Group.
    Mov Disord; 2006 May 25; 21(5):616-23. PubMed ID: 16450340
    [Abstract] [Full Text] [Related]

  • 8. Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.
    Smith KM, Eyal E, Weintraub D, ADAGIO Investigators.
    JAMA Neurol; 2015 Jan 25; 72(1):88-95. PubMed ID: 25420207
    [Abstract] [Full Text] [Related]

  • 9. Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease.
    Guay DR.
    Am J Geriatr Pharmacother; 2006 Dec 25; 4(4):330-46. PubMed ID: 17296539
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy, safety and tolerability of rasagiline as adjunctive therapy in elderly patients with Parkinson's disease.
    Tolosa E, Stern MB.
    Eur J Neurol; 2012 Feb 25; 19(2):258-64. PubMed ID: 21819487
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline.
    deMarcaida JA, Schwid SR, White WB, Blindauer K, Fahn S, Kieburtz K, Stern M, Shoulson I, Parkinson Study Group TEMPO, PRESTO Tyramine Substudy Investigators and Coordinators.
    Mov Disord; 2006 Oct 25; 21(10):1716-21. PubMed ID: 16856145
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease.
    Stocchi F, Rabey JM.
    Eur J Neurol; 2011 Dec 25; 18(12):1373-8. PubMed ID: 21895884
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.